Annual Revenue
$45.81 B
+$1.46 B+3.29%
31 December 2023
Summary
AstraZeneca annual revenue is currently $45.81 billion, with the most recent change of +$1.46 billion (+3.29%) on 31 December 2023. During the last 3 years, it has risen by +$19.19 billion (+72.11%). AZN annual revenue is now at all-time high.AZN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$13.56 B
+$627.00 M+4.85%
30 September 2024
Summary
AstraZeneca quarterly revenue is currently $13.56 billion, with the most recent change of +$627.00 million (+4.85%) on 30 September 2024. Over the past year, it has increased by +$2.07 billion (+18.04%). AZN quarterly revenue is now at all-time high.AZN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$51.21 B
+$2.07 B+4.22%
30 September 2024
Summary
AstraZeneca TTM revenue is currently $51.21 billion, with the most recent change of +$2.07 billion (+4.22%) on 30 September 2024. Over the past year, it has increased by +$6.21 billion (+13.81%). AZN TTM revenue is now at all-time high.AZN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | +18.0% | +13.8% |
| 3 y3 years | +72.1% | +37.5% | +56.0% |
| 5 y5 years | +107.4% | +111.8% | +112.2% |
AZN Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.1% | at high | +37.5% | at high | +56.0% |
| 5 y | 5 years | at high | +107.4% | at high | +116.2% | at high | +112.2% |
| alltime | all time | at high | +659.1% | at high | +784.5% | at high | +2828.6% |
AstraZeneca Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.56 B(+4.8%) | $51.21 B(+4.2%) |
| June 2024 | - | $12.94 B(+2.0%) | $49.13 B(+3.2%) |
| Mar 2024 | - | $12.68 B(+5.4%) | $47.61 B(+3.9%) |
| Dec 2023 | $45.81 B(+3.3%) | $12.02 B(+4.6%) | $45.81 B(+1.8%) |
| Sept 2023 | - | $11.49 B(+0.7%) | $44.99 B(+1.1%) |
| June 2023 | - | $11.42 B(+4.9%) | $44.48 B(+1.5%) |
| Mar 2023 | - | $10.88 B(-2.9%) | $43.84 B(-1.2%) |
| Dec 2022 | $44.35 B(+18.5%) | $11.21 B(+2.0%) | $44.35 B(-1.8%) |
| Sept 2022 | - | $10.98 B(+2.0%) | $45.15 B(+2.5%) |
| June 2022 | - | $10.77 B(-5.4%) | $44.04 B(+6.1%) |
| Mar 2022 | - | $11.39 B(-5.2%) | $41.49 B(+10.9%) |
| Dec 2021 | $37.42 B(+40.6%) | $12.01 B(+21.7%) | $37.42 B(+14.0%) |
| Sept 2021 | - | $9.87 B(+20.0%) | $32.82 B(+11.1%) |
| June 2021 | - | $8.22 B(+12.3%) | $29.53 B(+7.1%) |
| Mar 2021 | - | $7.32 B(-1.2%) | $27.58 B(+3.6%) |
| Dec 2020 | $26.62 B(+9.2%) | $7.41 B(+12.6%) | $26.62 B(+2.9%) |
| Sept 2020 | - | $6.58 B(+4.8%) | $25.87 B(+0.7%) |
| June 2020 | - | $6.28 B(-1.2%) | $25.70 B(+1.8%) |
| Mar 2020 | - | $6.35 B(-4.7%) | $25.25 B(+3.5%) |
| Dec 2019 | $24.38 B(+10.4%) | $6.66 B(+4.0%) | $24.38 B(+1.0%) |
| Sept 2019 | - | $6.41 B(+10.0%) | $24.14 B(+4.6%) |
| June 2019 | - | $5.82 B(+6.0%) | $23.07 B(+3.0%) |
| Mar 2019 | - | $5.49 B(-14.4%) | $22.40 B(+1.4%) |
| Dec 2018 | $22.09 B(-1.7%) | $6.42 B(+20.2%) | $22.09 B(+3.0%) |
| Sept 2018 | - | $5.34 B(+3.6%) | $21.45 B(-4.0%) |
| June 2018 | - | $5.16 B(-0.4%) | $22.34 B(+0.5%) |
| Mar 2018 | - | $5.18 B(-10.4%) | $22.24 B(-1.0%) |
| Dec 2017 | $22.46 B(-2.3%) | $5.78 B(-7.3%) | $22.46 B(+0.9%) |
| Sept 2017 | - | $6.23 B(+23.4%) | $22.27 B(+2.5%) |
| June 2017 | - | $5.05 B(-6.5%) | $21.74 B(-2.5%) |
| Mar 2017 | - | $5.41 B(-3.2%) | $22.29 B(-3.1%) |
| Dec 2016 | $23.00 B(-6.9%) | $5.58 B(-2.0%) | $23.00 B(-3.4%) |
| Sept 2016 | - | $5.70 B(+1.7%) | $23.82 B(-1.0%) |
| June 2016 | - | $5.60 B(-8.4%) | $24.06 B(-2.8%) |
| Mar 2016 | - | $6.12 B(-4.4%) | $24.77 B(+0.2%) |
| Dec 2015 | $24.71 B(-6.9%) | $6.40 B(+7.6%) | $24.71 B(-1.3%) |
| Sept 2015 | - | $5.95 B(-5.7%) | $25.02 B(-2.6%) |
| June 2015 | - | $6.31 B(+4.1%) | $25.69 B(-1.7%) |
| Mar 2015 | - | $6.06 B(-9.8%) | $26.14 B(-1.5%) |
| Dec 2014 | $26.55 B(+2.9%) | $6.72 B(+1.6%) | $26.55 B(-0.8%) |
| Sept 2014 | - | $6.61 B(-2.3%) | $26.77 B(+1.4%) |
| June 2014 | - | $6.76 B(+4.7%) | $26.41 B(+2.0%) |
| Mar 2014 | - | $6.46 B(-6.9%) | $25.88 B(+0.3%) |
| Dec 2013 | $25.81 B(-7.7%) | $6.94 B(+11.0%) | $25.81 B(-1.3%) |
| Sept 2013 | - | $6.25 B(+0.3%) | $26.15 B(-1.6%) |
| June 2013 | - | $6.23 B(-2.4%) | $26.58 B(-1.6%) |
| Mar 2013 | - | $6.38 B(-12.3%) | $27.01 B(-3.4%) |
| Dec 2012 | $27.97 B(-16.7%) | $7.28 B(+9.0%) | $27.97 B(-4.7%) |
| Sept 2012 | - | $6.68 B(+0.3%) | $29.35 B(-5.0%) |
| June 2012 | - | $6.66 B(-9.4%) | $30.88 B(-5.4%) |
| Mar 2012 | - | $7.35 B(-15.1%) | $32.65 B(-2.8%) |
| Dec 2011 | $33.59 B(+1.0%) | $8.66 B(+5.4%) | $33.59 B(+0.1%) |
| Sept 2011 | - | $8.21 B(-2.6%) | $33.55 B(+0.9%) |
| June 2011 | - | $8.43 B(+1.7%) | $33.24 B(+0.8%) |
| Mar 2011 | - | $8.29 B(-3.8%) | $32.98 B(-0.9%) |
| Dec 2010 | $33.27 B(+1.4%) | $8.62 B(+9.1%) | $33.27 B(-1.0%) |
| Sept 2010 | - | $7.90 B(-3.4%) | $33.60 B(-0.9%) |
| June 2010 | - | $8.18 B(-4.6%) | $33.90 B(+0.7%) |
| Mar 2010 | - | $8.58 B(-4.1%) | $33.68 B(+2.7%) |
| Dec 2009 | $32.80 B(+3.8%) | $8.95 B(+9.1%) | $32.80 B(+2.3%) |
| Sept 2009 | - | $8.20 B(+3.0%) | $32.05 B(+1.3%) |
| June 2009 | - | $7.96 B(+3.3%) | $31.63 B(+0.0%) |
| Mar 2009 | - | $7.70 B(-6.0%) | $31.63 B(+0.1%) |
| Dec 2008 | $31.60 B | $8.19 B(+5.4%) | $31.60 B(+0.1%) |
| Sept 2008 | - | $7.78 B(-2.3%) | $31.58 B(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | $7.96 B(+3.6%) | $30.95 B(+2.3%) |
| Mar 2008 | - | $7.68 B(-6.0%) | $30.27 B(+2.4%) |
| Dec 2007 | $29.56 B(+11.6%) | $8.17 B(+14.3%) | $29.56 B(+3.6%) |
| Sept 2007 | - | $7.15 B(-1.7%) | $28.54 B(+2.3%) |
| June 2007 | - | $7.27 B(+4.4%) | $27.91 B(+2.4%) |
| Mar 2007 | - | $6.97 B(-2.6%) | $27.26 B(+3.0%) |
| Dec 2006 | $26.48 B(+10.5%) | $7.15 B(+9.8%) | $26.48 B(+3.4%) |
| Sept 2006 | - | $6.52 B(-1.6%) | $25.61 B(+2.9%) |
| June 2006 | - | $6.63 B(+7.2%) | $24.88 B(+2.0%) |
| Mar 2006 | - | $6.18 B(-1.7%) | $24.39 B(+1.8%) |
| Dec 2005 | $23.95 B(+11.8%) | $6.29 B(+8.6%) | $23.95 B(+2.1%) |
| Sept 2005 | - | $5.79 B(-5.6%) | $23.46 B(+2.3%) |
| June 2005 | - | $6.13 B(+6.8%) | $22.94 B(+3.8%) |
| Mar 2005 | - | $5.74 B(-1.0%) | $22.09 B(+3.1%) |
| Dec 2004 | $21.43 B(+13.7%) | $5.80 B(+10.1%) | $21.43 B(+4.5%) |
| Sept 2004 | - | $5.26 B(-0.4%) | $20.50 B(+2.4%) |
| June 2004 | - | $5.29 B(+4.2%) | $20.01 B(+4.3%) |
| Mar 2004 | - | $5.07 B(+4.1%) | $19.18 B(+1.8%) |
| Dec 2003 | $18.85 B(+5.6%) | $4.88 B(+2.0%) | $18.85 B(+0.8%) |
| Sept 2003 | - | $4.78 B(+7.3%) | $18.69 B(+1.7%) |
| June 2003 | - | $4.45 B(-6.1%) | $18.38 B(+0.8%) |
| Mar 2003 | - | $4.74 B(+0.5%) | $18.24 B(+2.2%) |
| Dec 2002 | $17.84 B(+8.3%) | $4.72 B(+5.6%) | $17.84 B(+1.6%) |
| Sept 2002 | - | $4.47 B(+3.6%) | $17.56 B(+3.0%) |
| June 2002 | - | $4.31 B(-0.8%) | $17.05 B(+1.3%) |
| Mar 2002 | - | $4.35 B(-2.1%) | $16.84 B(+2.2%) |
| Dec 2001 | $16.48 B(-9.0%) | $4.44 B(+12.4%) | $16.47 B(-11.0%) |
| Sept 2001 | - | $3.95 B(-3.6%) | $18.50 B(+1.0%) |
| June 2001 | - | $4.10 B(+3.0%) | $18.33 B(+0.7%) |
| Mar 2001 | - | $3.98 B(-38.6%) | $18.21 B(+0.5%) |
| Dec 2000 | $18.12 B(+19.7%) | $6.48 B(+71.6%) | $18.12 B(+34.7%) |
| Sept 2000 | - | $3.77 B(-5.1%) | $13.45 B(-3.6%) |
| June 2000 | - | $3.98 B(+2.3%) | $13.96 B(-3.8%) |
| Mar 2000 | - | $3.89 B(+114.5%) | $14.50 B(-4.2%) |
| Dec 1999 | $15.13 B(+33.7%) | $1.81 B(-57.7%) | $15.13 B(-12.9%) |
| Sept 1999 | - | $4.28 B(-5.4%) | $17.38 B(+12.6%) |
| June 1999 | - | $4.52 B(0.0%) | $15.43 B(+9.4%) |
| Mar 1999 | - | $4.52 B(+11.4%) | $14.10 B(+17.5%) |
| Dec 1998 | $11.32 B(+31.8%) | $4.06 B(+74.2%) | $12.00 B(+17.3%) |
| Sept 1998 | - | $2.33 B(-27.0%) | $10.23 B(+2.3%) |
| June 1998 | - | $3.19 B(+32.0%) | $10.00 B(+10.0%) |
| Mar 1998 | - | $2.42 B(+5.7%) | $9.09 B(+1.5%) |
| Dec 1997 | $8.59 B(-6.5%) | $2.29 B(+9.0%) | $8.96 B(-20.2%) |
| Sept 1997 | - | $2.10 B(-8.1%) | $11.22 B(-1.9%) |
| June 1997 | - | $2.28 B(0.0%) | $11.44 B(+0.0%) |
| Mar 1997 | - | $2.28 B(-49.9%) | $11.43 B(+0.0%) |
| Dec 1996 | $9.18 B(+21.3%) | $4.56 B(+97.0%) | $11.43 B(+32.4%) |
| Sept 1996 | - | $2.31 B(+1.5%) | $8.63 B(+4.6%) |
| June 1996 | - | $2.28 B(0.0%) | $8.26 B(+3.3%) |
| Mar 1996 | - | $2.28 B(+29.2%) | $7.99 B(+3.4%) |
| Dec 1995 | $7.57 B(+8.1%) | $1.76 B(-8.9%) | $7.73 B(-0.8%) |
| Sept 1995 | - | $1.94 B(-4.1%) | $7.80 B(+2.4%) |
| June 1995 | - | $2.02 B(-0.0%) | $7.61 B(+2.4%) |
| Mar 1995 | - | $2.02 B(+10.4%) | $7.43 B(+2.5%) |
| Dec 1994 | $7.00 B(+6.6%) | $1.83 B(+4.2%) | $7.25 B(+4.2%) |
| Sept 1994 | - | $1.75 B(-4.6%) | $6.96 B(+3.2%) |
| June 1994 | - | $1.84 B(0.0%) | $6.74 B(+1.3%) |
| Mar 1994 | - | $1.84 B(+19.8%) | $6.66 B(+1.3%) |
| Dec 1993 | $6.57 B(+8.8%) | $1.53 B(-0.2%) | $6.57 B(+30.5%) |
| Sept 1993 | - | $1.54 B(-12.1%) | $5.03 B(+44.0%) |
| June 1993 | - | $1.75 B(0.0%) | $3.50 B(+100.0%) |
| Mar 1993 | - | $1.75 B | $1.75 B |
| Dec 1992 | $6.03 B(-17.9%) | - | - |
| Dec 1991 | $7.35 B(+0.0%) | - | - |
| Dec 1990 | $7.35 B | - | - |
FAQ
- What is AstraZeneca annual revenue?
- What is the all time high annual revenue for AstraZeneca?
- What is AstraZeneca annual revenue year-on-year change?
- What is AstraZeneca quarterly revenue?
- What is the all time high quarterly revenue for AstraZeneca?
- What is AstraZeneca quarterly revenue year-on-year change?
- What is AstraZeneca TTM revenue?
- What is the all time high TTM revenue for AstraZeneca?
- What is AstraZeneca TTM revenue year-on-year change?
What is AstraZeneca annual revenue?
The current annual revenue of AZN is $45.81 B
What is the all time high annual revenue for AstraZeneca?
AstraZeneca all-time high annual revenue is $45.81 B
What is AstraZeneca annual revenue year-on-year change?
Over the past year, AZN annual revenue has changed by +$1.46 B (+3.29%)
What is AstraZeneca quarterly revenue?
The current quarterly revenue of AZN is $13.56 B
What is the all time high quarterly revenue for AstraZeneca?
AstraZeneca all-time high quarterly revenue is $13.56 B
What is AstraZeneca quarterly revenue year-on-year change?
Over the past year, AZN quarterly revenue has changed by +$2.07 B (+18.04%)
What is AstraZeneca TTM revenue?
The current TTM revenue of AZN is $51.21 B
What is the all time high TTM revenue for AstraZeneca?
AstraZeneca all-time high TTM revenue is $51.21 B
What is AstraZeneca TTM revenue year-on-year change?
Over the past year, AZN TTM revenue has changed by +$6.21 B (+13.81%)